On June 18, 2020, the Food and Drug Administration granted accelerated approval to tazemetostat (TAZVERIK), the first-in-class EZH2 inhibitor. The...
Epizyme
Ipsen announced that it entered into a definitive merger agreement to acquire Epizyme. The acquisition is anticipated to be closed...
